Richard A. Padgett
Affiliations: | Molecular Genetics | The Cleveland Clinic, Cleveland, OH, United States |
Website:
http://www.lerner.ccf.org/molgen/padgett/Google:
"Richard A. Padgett"Bio:
http://my.clevelandclinic.org/staff_directory/staff_display.aspx?DoctorID=1900
http://searchworks.stanford.edu/view/5606777
Mean distance: 8.53 | S | N | B | C | P |
Parents
Sign in to add mentor| George R. Stark | grad student | 1981 | Stanford | |
| (Gene amplification in Syrian hamster cells resistant to N-(phosphonacetyl)-L-aspartate) | ||||
| Phillip Allen Sharp | post-doc | 1981-1985 | MIT | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Durmaz A, Gurnari C, Hershberger CE, et al. (2023) A multimodal analysis of genomic and RNA splicing features in myeloid malignancies. Iscience. 26: 106238 |
| Daniels NJ, Hershberger CE, Gu X, et al. (2021) Functional analyses of human LUC7-like proteins involved in splicing regulation and myeloid neoplasms. Cell Reports. 35: 108989 |
| Hershberger CE, Daniels NJ, Padgett RA. (2020) Spliceosomal factor mutations and mis-splicing in MDS. Best Practice & Research. Clinical Haematology. 33: 101199 |
| Hershberger CE, Moyer DC, Adema V, et al. (2020) Complex landscape of alternative splicing in myeloid neoplasms. Leukemia |
| Benoit-Pilven C, Besson A, Putoux A, et al. (2020) Clinical interpretation of variants identified in RNU4ATAC, a non-coding spliceosomal gene. Plos One. 15: e0235655 |
| Moyer DC, Larue GE, Hershberger CE, et al. (2020) Comprehensive database and evolutionary dynamics of U12-type introns. Nucleic Acids Research |
| Padgett RA. (2019) New roles for old RNA cap flavors. Nature Chemical Biology. 15: 317-318 |
| Adema V, Hershberger CE, Walter W, et al. (2019) Hotspot U2AF1 Mutations Determine Missplicing Selectivity: Novel Mechanisms Altering Splicing Factors Blood. 134: 2985-2985 |
| Hershberger CE, Moyer DC, Walter W, et al. (2019) The Biological and Clinical Implications of the Alternative Splicing Landscape of 1,258 Myeloid Neoplasm Cases Blood. 134: 769-769 |
| Visconte V, Przychodzen BP, Adema V, et al. (2018) Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies Blood. 132: 211-211 |